EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+9.23%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$5.08B
AUM Growth
+$407M
(+8.7%)
Cap. Flow
+$218M
Cap. Flow
% of AUM
4.29%
Top 10 Holdings %
Top 10 Hldgs %
23.59%
Holding
154
New
18
Increased
54
Reduced
21
Closed
16
Top Buys
| 1 |
Biohaven
BHVN
|
$74.9M |
| 2 |
Doximity
DOCS
|
$57.4M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$55.8M |
| 4 |
DoubleVerify
DV
|
$50.5M |
| 5 |
MongoDB
MDB
|
$40.3M |
Top Sells
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$165M |
| 2 |
Cogent Biosciences
COGT
|
$33.3M |
| 3 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$33.2M |
| 4 |
Duolingo
DUOL
|
$33.1M |
| 5 |
Kura Oncology
KURA
|
$32.8M |
Sector Composition
| 1 | Healthcare | 38.81% |
| 2 | Technology | 25% |
| 3 | Industrials | 15.64% |
| 4 | Consumer Discretionary | 5.21% |
| 5 | Utilities | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FRLN
126
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
| $4.09M | 0.08% |
396,667
| – | – |
|
127
KalVista Pharmaceuticals
KALV
$715M
| $4.01M | 0.08% |
+276,200
| New | +$4.01M |
|
128
Sherwin-Williams
SHW
$90.9B
| $3.83M | 0.08% |
18,692
+192
| +1% | +$39.3K |
|
129
Pharvaris
PHVS
$1.41B
| $3.62M | 0.07% |
450,251
| – | – |
|
130
EQT Corp
EQT
$32.1B
| $3.34M | 0.07% |
+81,934
| New | +$3.34M |
|
131
ESSA Pharma
EPIX
$11.1M
| $2.84M | 0.06% |
1,561,251
-1,804,317
| -54% | -$3.28M |
|
132
Arteris
AIP
$372M
| $2.64M | 0.05% |
396,021
+197,512
| +99% | +$1.32M |
|
133
Compass Therapeutics
CMPX
$470M
| $2.51M | 0.05% |
+1,100,399
| New | +$2.51M |
|
134
Targa Resources
TRGP
$35.5B
| $2.18M | 0.04% |
36,200
-69,822
| -66% | -$4.21M |
|
135
BILL Holdings
BILL
$4.68B
| $1.66M | 0.03% |
+12,500
| New | +$1.66M |
|
136
Advanced Drainage Systems
WMS
$11.1B
| $1.09M | 0.02% |
8,752
-31,300
| -78% | -$3.89M |
|
137
Prologis
PLD
$104B
| $1.06M | 0.02% |
10,400
-39,113
| -79% | -$3.98M |
|
138
Cognex
CGNX
$7.33B
| – | – |
-359,000
| Closed | -$15.3M |
|
139
Ciena
CIEN
$16.4B
| – | – |
-32,000
| Closed | -$1.46M |
|
140
Design Therapeutics
DSGN
$334M
| – | – |
-281,569
| Closed | -$3.94M |
|
|
141
Duolingo
DUOL
$12.6B
| – | – |
-378,375
| Closed | -$33.1M |
|
142
Garmin
GRMN
$46.3B
| – | – |
-55,700
| Closed | -$5.47M |
|
143
KB Home
KBH
$4.37B
| – | – |
-35,100
| Closed | -$999K |
|
|
144
Kura Oncology
KURA
$701M
| – | – |
-1,790,144
| Closed | -$32.8M |
|
145
Live Oak Bancshares
LOB
$1.72B
| – | – |
-136,983
| Closed | -$4.64M |
|
146
monday.com
MNDY
$9.26B
| – | – |
-20,409
| Closed | -$2.11M |
|
147
Nurix Therapeutics
NRIX
$704M
| – | – |
-1,154,000
| Closed | -$14.6M |
|
148
Phathom Pharmaceuticals
PHAT
$840M
| – | – |
-336,223
| Closed | -$2.84M |
|
149
Silicon Laboratories
SLAB
$4.29B
| – | – |
-19,137
| Closed | -$2.68M |
|
150
Vital Farms
VITL
$2.21B
| – | – |
-950,092
| Closed | -$8.31M |
|